China Technology Group (01725) plans to issue a total of approximately 251 million new shares, raising a net of approximately 138 million Hong Kong dollars.
China Technology Group (01725) announced that on December 5, 2025 (after trading hours), the company entered into a subscription agreement with subscribers (Ms. Zhong Li and Mr. Xie Changlun) to issue approximately 161 million subscription shares to the subscribers at a price of HK$0.560 per share, representing a discount of approximately 20.00% to the closing price of HK$0.700 per share on the last trading day on the Stock Exchange. In addition, the company plans to distribute up to 90 million placement shares through placement agents at a price of HK$0.560 per share.
China Technology Group (01725) announced that on December 5, 2025 (after trading hours), the company entered into a subscription agreement with subscribers (Ms. Zhong Li and Mr. Xie Changlun), proposing to issue approximately 161 million subscription shares to subscribers at a price of HK$0.560 per share, representing a discount of approximately 20.00% from the closing price of HK$0.700 per share on the last trading day on the Stock Exchange of Hong Kong.
In addition, the company intends to sell up to 90 million placement shares through placement agents at a price of HK$0.560 per share.
Assuming all placement shares are successfully sold, the net proceeds from the subscription and placement activities will be approximately HK$138 million, with 65.31% to be used to repay shareholder loans and 34.69% to be used for general operating funds of the group, including but not limited to salaries, rent, professional fees, and office expenses.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






